Quality Measure Implementation Guide (STU3)
3.0.0 - STU 3 US

This page is part of the Quality Measure STU2 for FHIR R4 Implementation Guide (v3.0.0: STU3) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Measure: Breast Cancer Screening FHIR Measure

Active as of 2022-02-22
Id: BreastCancerScreeningFHIR
Url: http://ecqi.healthit.gov/ecqms/Measure/BreastCancerScreeningFHIR
Version: 2.0.003
Identifier:

value: 125

Identifier:

type:

value: urn:uuid:11873bc9-ca0a-4cf3-b8f2-605a950aac74

Identifier:

type:

value: urn:uuid:b366f29b-347f-464e-8064-c83842d825c7

Identifier:

type:

value: BCS-FHIR

Name: BreastCancerScreeningFHIR
Title: Breast Cancer Screening FHIR Measure
Status: active
Experimental: false
Scoring:

system: http://terminology.hl7.org/CodeSystem/measure-scoring

code: proportion

display: Proportion

Improvement Notation:

system: http://terminology.hl7.org/CodeSystem/measure-improvement-notation

code: increase

Type:

system: http://terminology.hl7.org/CodeSystem/measure-type

code: process

Date: 2022-02-22T11:37:03-06:00
Publisher: Clinical Quality Information WG
Description: Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the Measurement Period
Use Context:
codevalue
program
Jurisdiction: US
Purpose: Unknown
Copyright: This Physician Performance Measure (Measure) and related data specifications are owned and were developed by the National Committee for Quality Assurance (NCQA). NCQA is not responsible for any use of the Measure. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in the Measure. The Measure can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by healthcare providers in connection with their practices) without obtaining approval from NCQA. Commercial use is defined as the sale, licensing, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. All commercial uses or requests for modification must be approved by NCQA and are subject to a license at the discretion of NCQA. (C) 2012-2019 National Committee for Quality Assurance. All Rights Reserved. Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. NCQA disclaims all liability for use or accuracy of any third party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2019 American Medical Association. LOINC(R) copyright 2004-2019 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2019 International Health Terminology Standards Development Organisation. ICD-10 copyright 2019 World Health Organization. All Rights Reserved.
Disclaimer: The performance Measure is not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications. THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].
Approval Date: 2019-03-08
Last Review Date: 2019-03-08
Effective Period: 2021-01-01..2021-12-31

Contained resources